Alphamab Oncology (9966.HK)
HKD 3.54
(-1.67%)
HKD 3.54
(-1.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 218.77 Million | 166.84 Million | 146.02 Million | - | 4.99 Million | -735 Thousand |
| Cost of Revenue | 55.23 Million | 44.2 Million | 3.02 Million | - | - | - |
| Gross Profit | 163.53 Million | 122.63 Million | 142.99 Million | - | 4.99 Million | -735 Thousand |
| Operating Expenses | 163.53 Million | 468.02 Million | 570.03 Million | 480.6 Million | 315.95 Million | 96.02 Million |
| Selling, General and Administrative Expenses | 79.33 Million | 86.94 Million | 77.55 Million | 78.2 Million | 154.29 Million | 13.31 Million |
| Research and Development Expenses | 407.52 Million | 468.23 Million | 481.36 Million | 331.24 Million | 166.65 Million | 65.6 Million |
| Other Expenses | - | 473 Thousand | 5.36 Million | - | -4.99 Million | -27.37 Million |
| Cost and Expenses | 524.32 Million | 512.22 Million | 573.06 Million | 480.6 Million | 315.95 Million | 96.02 Million |
| Operating Income | -305.55 Million | -432.37 Million | -415.61 Million | -409.44 Million | -829.13 Million | -131.7 Million |
| Interest Expense | 12.17 Million | 14.2 Million | 13.18 Million | - | 3.6 Million | 1.5 Million |
| Income Tax Expense | - | 40.31 Million | 28.28 Million | - | 3.6 Million | 16.62 Million |
| Earnings before Tax | -210.59 Million | -325.72 Million | -412.41 Million | -427.76 Million | -832.74 Million | -202.63 Million |
| Net Income | -210.59 Million | -325.72 Million | -412.41 Million | -427.76 Million | -836.34 Million | -149.84 Million |
| Earnings Per Share Basic | -0.22 | -0.35 | -0.44 | -0.46 | -1.56 | -0.17 |
| Earnings Per Share Diluted | -0.22 | -0.35 | -0.44 | -0.46 | -1.56 | -0.17 |
| Weighted Average Shares Outstanding | 959.89 Million | 930.63 Million | 935.48 Million | 929.75 Million | 536.53 Million | 897.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 959.89 Million | 936.5 Million | 935.48 Million | 929.74 Million | 536.53 Million | 897.01 Million |
| Gross Margin | 0.75 | 0.74 | 0.98 | - | 1.00 | 1.00 |
| EBIT Margin | -0.59 | -2.35 | -2.65 | - | -163.73 | 170.27 |
| Profit Margin | -0.96 | -1.95 | -2.82 | - | -167.54 | 203.87 |
| EBITDA | -129.29 Million | -391.82 Million | -358.13 Million | -390.46 Million | -277.57 Million | -91.93 Million |
| Earnings Before Tax Margin | -1.40 | -2.59 | -2.85 | - | -166.09 | 179.19 |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 173.56 Million | 82.3 Million | 218.77 Million | 136.46 Million | 113.27 Million | 166.84 Million |
| Cost of Revenue | 30.8 Million | 22.07 Million | 55.23 Million | 33.16 Million | 29.38 Million | 44.2 Million |
| Gross Profit | 142.75 Million | 60.23 Million | 163.53 Million | 103.3 Million | 83.88 Million | 122.63 Million |
| Operating Expenses | 229.25 Million | 258.97 Million | 469.08 Million | 173.92 Million | 276.95 Million | 468.02 Million |
| Selling, General and Administrative Expenses | 34.72 Million | 46.13 Million | - | 33.43 Million | 42.67 Million | - |
| Research and Development Expenses | 194.53 Million | 212.84 Million | - | 194.68 Million | 251.83 Million | - |
| Other Expenses | - | - | -95 Thousand | - | - | 473 Thousand |
| Cost and Expenses | 260.05 Million | 281.04 Million | 524.32 Million | 207.09 Million | 306.34 Million | 512.22 Million |
| Operating Income | -86.49 Million | -198.73 Million | -323.32 Million | -124.62 Million | -210.62 Million | -432.37 Million |
| Interest Expense | - | - | 12.17 Million | - | - | 14.2 Million |
| Income Tax Expense | 86 Thousand | 38 Thousand | 124.91 Million | - | - | 40.31 Million |
| Earnings before Tax | -44.89 Million | -170.73 Million | -210.59 Million | -39.86 Million | -178.41 Million | -325.72 Million |
| Net Income | -44.89 Million | -170.73 Million | -210.59 Million | -39.86 Million | -178.41 Million | -325.72 Million |
| Earnings Per Share Basic | -0.05 | -0.18 | - | -0.04 | -0.19 | - |
| Earnings Per Share Diluted | -0.05 | -0.18 | - | -0.04 | -0.19 | - |
| Weighted Average Shares Outstanding | 897.92 Million | 950.62 Million | 959.89 Million | 957.16 Million | 936.92 Million | 930.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 962.8 Million | 962.65 Million | 959.89 Million | 957.14 Million | 936.91 Million | 936.5 Million |
| Gross Margin | 0.82 | 0.73 | 0.75 | 0.76 | 0.74 | 0.74 |
| EBIT Margin | -0.32 | -2.05 | - | -0.73 | -1.64 | - |
| Profit Margin | -0.26 | -2.07 | -0.96 | -0.29 | -1.58 | -1.95 |
| EBITDA | -55.62 Million | -168.52 Million | - | -99.02 Million | -186 Million | - |
| Earnings Before Tax Margin | -0.50 | -2.41 | -1.48 | -0.91 | -1.86 | -2.59 |
GRL
EW
PLAOU
MRMD
HUYA
9900